Filter
137
Filtered Results: 137
Text search:
UNITAID,
WHO,
Global
Laboratory
Initiative,
et.
al
Featured
Recommendations
16
New Publications
29
Language
Document type
No document type
69
Studies & Reports
26
Guidelines
24
Strategic & Response Plan
8
Manuals
6
Training Material
1
Brochures
1
Infographics
1
Fact sheets
1
Countries / Regions
Global
5
India
4
Africa
3
Eastern Europe
3
Ethiopia
3
Kenya
2
Cameroon
2
Burkina Faso
2
Mozambique
2
Western and Central Europe
2
Uganda
2
Myanmar / Burma
2
Timor Leste/ East Timor
1
Nigeria
1
Malawi
1
Asia
1
West and Central Africa
1
Middle East and North Africa
1
East and Southern Africa
1
Bangladesh
1
Brazil
1
Moldova
1
Liberia
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
11
HIV & STI
11
Policies
8
TB
7
Hepatitis
6
Studies & Reports
5
Paediatrics
3
Pediatrics
3
Drugs & Medical Equipment
3
Communicable Diseases
2
COVID-19
2
Virology
2
Vaccine-preventable Diseases
2
Guidelines
2
Statistics
2
Neonatal Care
2
Emergency Health Kits
1
Bacteriology
1
Cancer
1
Cervical Cancer
1
Infection Control & Prevention (IPC)
1
Medical Devices & Equipment
1
Clinical Guidelines
1
Demograhic Health Surveys DHS
1
Community Health
1
Other
1
Surgery & Anaesthesia
1
Maternal Health
1
Primary Health Care
1
Parasitology
1
Disease Prevention & Control
1
Reproductive Health
1
Pharmacy & Technologies
1
Toolboxes
HIV testing & services
13
Clinical Aspects, Treatment & Prevention
9
Detection & Diagnosis
8
Antiretroviral Treatment ART
8
Treatment & Prevention
6
Prevention & Control
6
Treatment Guidelines HIV
5
Access to treatment and laboratory
4
Drug resistant TB
4
Clinical Aspects
3
Adults
3
Children & Adolescents
3
International
3
General Information & Methodology
3
Testing Guidelines
3
Reports & Studies Children HIV
3
Reports & Studies
3
Policies & Strategies
2
ART Drug Resistance
2
Meningitis Prevention & Control
2
General Reports
2
Childhood TB
2
Policies
2
HIV testing & disclosure
2
Global
2
Universal Health Coverage UHC and 90-90-90 Strategy
2
Diagnostics & Laboratory Guidance
2
Surveillance & Contact tracing
2
Rational use of Medicine
2
Pharmacovigilance
2
Co-Morbidities (except TB)
2
TB/HIV Global
2
Research & Access
2
Eastern Europe & Central Asia
2
Azerbaijan
1
Vaccines & Immunization
1
Opportunistic Infections
1
Hepatitis
1
Public Health
1
Children
1
Human Rights
1
General
1
Treatment Guidelines
1
Prevention & Preparedness
1
Studies
1
Essential List
1
Public Health
1
HIV and COVID-19
1
COVID-19
1
Hospital Readiness/Essential Health Services
1
Access & Strategy
1
TB/COVID-19
1
Long COVID/ Post-COVID Syndrome
1
Advocacy & Communication
1
Overview
1
Essential Medicines & Devices Lists
1
Pediatrics
1
Guidelines & Manuals
1
Emergency health kits
1
Emergency health kits
1
Health Financing Toolbox
1
Women
1
Policies and guidelines
1
Training
1
Clinical Guidelines
1
HIV and coinfection
1
TB/HIV Coinfection
1
Epidemiology
1
Community-based Mental Health Care
1
Lobby and Advocacy
1
Epidemiology
1
Meningitis & Encephalitis
1
Eastern and Southern Africa
1
SEAR (South-east Asia Region)
1
Eastern Europe and central Asia
1
The Interagency Emergency Health Kit 2017
recommended
Interagency Guidelines; Medicines and medical devices for 10 000 people for approximately three month.
These consolidated guidelines on HIV testing services (HTS) bring together existing and new guidance on HTS across different settings and populations.
The World Health Organization (WHO) first released consolidated guidelines on HTS in 2015, in response to requests from Member States, national pr...
Цель настоящего документа («Основные положения») заключается в подготовке рекомендаций относительно необходимых на национальном уровне мер по адаптации стратег...
L’accessibilité géographique et financière constante des médicaments essentiels de qualité,
sûrs et efficaces aux populations est un objectif majeur des politiques pharmaceutiques
nationales.
Pour atteindre cet objectif, le Ministère de la Santé du Burkina Faso a mis en place un systèm...
2nd edition. The 2018 Roadmap incorporates an additional critical population: adolescents. Despite making up 1 in 6 of the world’s people, adolescents have been largely overlooked as global momentum to address TB has grown. Spanning the ages of 10–19 years, adolescents are both at risk of TB and...
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
July 2018
This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes the current HIV testing gap; the challenges facing efforts to scale up; and the potential role HIV self-testing (HIVST) could play to achieve the United...
Fever Diagnostic Technology Landscape
recommended
1st edition.
Unitaid’s report describes a slate of new devices that can more efficiently identify dangerously ill children so that they can be treated immediately. These tools make it easier to recognize danger signs, and support integrated approaches to reducing childhood deaths from the three ...
Joint Action for Results
UNAIDS Outcome Framework: Business Case 2009–2011
The new WHO guidelines recommend that people living with HIV be started on antiretrovirals (ARVs) as soon as possible after being diagnosed. Currently, many people living with the virus globally must wait until their CD4 counts fall to 500 to start treatment. According to the WHO, the move to early ...
The Guide to operationalize HIV viral load testing HIV presents 60 lessons learnt from the project in a systemic approach including: viral load strategy, laboratories, procurement and supply management, patient care and economy.
A global Review of evidence and practice
From policy to practice: how the TB-HIV response is working
“The HIV community must place much more focus on TB co-infection than
it has done to date. TB takes the lives of over 1000 people living with HIV
every day, a number which is absolutely unacceptable. This report highlights that
TB d...
Orientations provisoires, 16 novembre 2020
Ce document d’orientation a été conçu à l’intention des autorités nationales chargées de gérer le déploiement, la mise en œuvre et le suivi des vaccins contre la COVID-19, ainsi que des partenaires qui fourniss...
La méningite est mortelle et débilitante ; elle frappe brutalement ; elle a de graves conséquences sanitaires, économiques et sociales et touche tous les âges de la vie dans tous les pays du monde. La méningite bactérienne peut être à l’origine d’épidémies, entraîner la mort dans les...
The roadmap describes the actions needed to
achieve the three development goals for TB
vaccines set by the WHO:
1. A safe, effective and affordable TB vaccine
for adolescents and adults.
2. An affordable TB vaccine for neonates and
infants with improved safety and efficacy.
3. A therapeutic v...
Malgré les progrès récents vers la mise au point d’un traitement hautement efficace et abordable contre le virus de l’hépatite C, beaucoup de personnes infectées par ce virus ne connaissent pas leur statut. L’Organisation mondiale de la Santé (OMS) estime qu’en 2019, 58 millions ...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
